PRMT2, another overexpressed PRMT protein, confers poor patient prognosis, and knockout of PRMT2 causes reductions of phosphorylated STAT3, AKT, and MAPK in glioma cell lines [31]. This evidence concerns the gene PRMT2 and glioma.